{
  "timestamp": "2026-01-05T08:34:13.834425",
  "trigger": "after_safety_triage",
  "agent_id": "safety_triage",
  "context": {
    "user_assist": {
      "summary": "Follow-up session evaluating severe exacerbation of depressive symptoms, including significant functional impairment, vegetative symptoms, and passive suicidal ideation, leading to an adjustment of the current antidepressant regimen.",
      "clinical_nature": "follow-up",
      "validation_result": "approved",
      "reasoning": "The clinical discussion centers on the efficacy of a previously initiated medication (*Sertraline*) and includes necessary screening for severe depressive symptoms and passive suicidal ideation, which is crucial for appropriate treatment planning and risk management."
    },
    "safety_triage": {
      "risk_detected": true,
      "clarification_needed": false,
      "clarification_question": "",
      "suggested_answer": "",
      "concerns": [
        {
          "type": "Suicide Risk",
          "severity": "Moderate",
          "evidence": "Sometimes I think they'd be better off without me dragging them down. / But I just wish I could disappear sometimes.",
          "recommended_action": "The patient reports significant passive suicidal ideation (wish to die/non-existence) linked to intense guilt and hopelessness. However, the patient explicitly denied intent or plan ('No, no, I wouldn't do that. I couldn't do that to them.'). Safety planning and close, frequent monitoring for escalation are essential, particularly given the planned medication dose increase."
        }
      ],
      "summary": "Patient exhibits severe vegetative and cognitive symptoms of depression (anhedonia, early morning awakening, weight loss, impaired function) and passive suicidal ideation. Active intent and plan are denied, but the level of hopelessness warrants designation as Moderate Risk."
    }
  }
}